The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biobanking Technologies Market Research Report 2025
Synopsis
The global Biobanking Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biobanking Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biobanking Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biobanking Technologies in Regenerative Medicine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biobanking Technologies include Thermo Fisher, Tecan Group, Qiagen, Hamilton, Brooks Automation, TTP Labtech, VWR, Promega and Worthington, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biobanking Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking Technologies.
Report Scope
The Biobanking Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biobanking Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
Greiner Bio One
Biokryo
Biobank
Biorep
Segment by Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Segment by Application
Regenerative Medicine
Life Science
Clinical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biobanking Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Biobanking Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biobanking Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biobanking Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biobanking Technologies in Regenerative Medicine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biobanking Technologies include Thermo Fisher, Tecan Group, Qiagen, Hamilton, Brooks Automation, TTP Labtech, VWR, Promega and Worthington, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biobanking Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking Technologies.
Report Scope
The Biobanking Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biobanking Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
Greiner Bio One
Biokryo
Biobank
Biorep
Segment by Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Segment by Application
Regenerative Medicine
Life Science
Clinical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biobanking Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biobanking Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Products
1.2.3 Human Tissues
1.2.4 Cell Lines
1.2.5 Nucleic Acids
1.3 Market by Application
1.3.1 Global Biobanking Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Regenerative Medicine
1.3.3 Life Science
1.3.4 Clinical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biobanking Technologies Market Perspective (2019-2030)
2.2 Biobanking Technologies Growth Trends by Region
2.2.1 Global Biobanking Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biobanking Technologies Historic Market Size by Region (2019-2024)
2.2.3 Biobanking Technologies Forecasted Market Size by Region (2025-2030)
2.3 Biobanking Technologies Market Dynamics
2.3.1 Biobanking Technologies Industry Trends
2.3.2 Biobanking Technologies Market Drivers
2.3.3 Biobanking Technologies Market Challenges
2.3.4 Biobanking Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biobanking Technologies Players by Revenue
3.1.1 Global Top Biobanking Technologies Players by Revenue (2019-2024)
3.1.2 Global Biobanking Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Biobanking Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biobanking Technologies Revenue
3.4 Global Biobanking Technologies Market Concentration Ratio
3.4.1 Global Biobanking Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biobanking Technologies Revenue in 2023
3.5 Biobanking Technologies Key Players Head office and Area Served
3.6 Key Players Biobanking Technologies Product Solution and Service
3.7 Date of Enter into Biobanking Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biobanking Technologies Breakdown Data by Type
4.1 Global Biobanking Technologies Historic Market Size by Type (2019-2024)
4.2 Global Biobanking Technologies Forecasted Market Size by Type (2025-2030)
5 Biobanking Technologies Breakdown Data by Application
5.1 Global Biobanking Technologies Historic Market Size by Application (2019-2024)
5.2 Global Biobanking Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biobanking Technologies Market Size (2019-2030)
6.2 North America Biobanking Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biobanking Technologies Market Size by Country (2019-2024)
6.4 North America Biobanking Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biobanking Technologies Market Size (2019-2030)
7.2 Europe Biobanking Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biobanking Technologies Market Size by Country (2019-2024)
7.4 Europe Biobanking Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biobanking Technologies Market Size (2019-2030)
8.2 Asia-Pacific Biobanking Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biobanking Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Biobanking Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biobanking Technologies Market Size (2019-2030)
9.2 Latin America Biobanking Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biobanking Technologies Market Size by Country (2019-2024)
9.4 Latin America Biobanking Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biobanking Technologies Market Size (2019-2030)
10.2 Middle East & Africa Biobanking Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biobanking Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Biobanking Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Biobanking Technologies Introduction
11.1.4 Thermo Fisher Revenue in Biobanking Technologies Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Tecan Group
11.2.1 Tecan Group Company Detail
11.2.2 Tecan Group Business Overview
11.2.3 Tecan Group Biobanking Technologies Introduction
11.2.4 Tecan Group Revenue in Biobanking Technologies Business (2019-2024)
11.2.5 Tecan Group Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Biobanking Technologies Introduction
11.3.4 Qiagen Revenue in Biobanking Technologies Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 Hamilton
11.4.1 Hamilton Company Detail
11.4.2 Hamilton Business Overview
11.4.3 Hamilton Biobanking Technologies Introduction
11.4.4 Hamilton Revenue in Biobanking Technologies Business (2019-2024)
11.4.5 Hamilton Recent Development
11.5 Brooks Automation
11.5.1 Brooks Automation Company Detail
11.5.2 Brooks Automation Business Overview
11.5.3 Brooks Automation Biobanking Technologies Introduction
11.5.4 Brooks Automation Revenue in Biobanking Technologies Business (2019-2024)
11.5.5 Brooks Automation Recent Development
11.6 TTP Labtech
11.6.1 TTP Labtech Company Detail
11.6.2 TTP Labtech Business Overview
11.6.3 TTP Labtech Biobanking Technologies Introduction
11.6.4 TTP Labtech Revenue in Biobanking Technologies Business (2019-2024)
11.6.5 TTP Labtech Recent Development
11.7 VWR
11.7.1 VWR Company Detail
11.7.2 VWR Business Overview
11.7.3 VWR Biobanking Technologies Introduction
11.7.4 VWR Revenue in Biobanking Technologies Business (2019-2024)
11.7.5 VWR Recent Development
11.8 Promega
11.8.1 Promega Company Detail
11.8.2 Promega Business Overview
11.8.3 Promega Biobanking Technologies Introduction
11.8.4 Promega Revenue in Biobanking Technologies Business (2019-2024)
11.8.5 Promega Recent Development
11.9 Worthington
11.9.1 Worthington Company Detail
11.9.2 Worthington Business Overview
11.9.3 Worthington Biobanking Technologies Introduction
11.9.4 Worthington Revenue in Biobanking Technologies Business (2019-2024)
11.9.5 Worthington Recent Development
11.10 Chart Industries
11.10.1 Chart Industries Company Detail
11.10.2 Chart Industries Business Overview
11.10.3 Chart Industries Biobanking Technologies Introduction
11.10.4 Chart Industries Revenue in Biobanking Technologies Business (2019-2024)
11.10.5 Chart Industries Recent Development
11.11 BD
11.11.1 BD Company Detail
11.11.2 BD Business Overview
11.11.3 BD Biobanking Technologies Introduction
11.11.4 BD Revenue in Biobanking Technologies Business (2019-2024)
11.11.5 BD Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Biobanking Technologies Introduction
11.12.4 Merck Revenue in Biobanking Technologies Business (2019-2024)
11.12.5 Merck Recent Development
11.13 Micronic
11.13.1 Micronic Company Detail
11.13.2 Micronic Business Overview
11.13.3 Micronic Biobanking Technologies Introduction
11.13.4 Micronic Revenue in Biobanking Technologies Business (2019-2024)
11.13.5 Micronic Recent Development
11.14 Panasonic
11.14.1 Panasonic Company Detail
11.14.2 Panasonic Business Overview
11.14.3 Panasonic Biobanking Technologies Introduction
11.14.4 Panasonic Revenue in Biobanking Technologies Business (2019-2024)
11.14.5 Panasonic Recent Development
11.15 Greiner Bio One
11.15.1 Greiner Bio One Company Detail
11.15.2 Greiner Bio One Business Overview
11.15.3 Greiner Bio One Biobanking Technologies Introduction
11.15.4 Greiner Bio One Revenue in Biobanking Technologies Business (2019-2024)
11.15.5 Greiner Bio One Recent Development
11.16 Biokryo
11.16.1 Biokryo Company Detail
11.16.2 Biokryo Business Overview
11.16.3 Biokryo Biobanking Technologies Introduction
11.16.4 Biokryo Revenue in Biobanking Technologies Business (2019-2024)
11.16.5 Biokryo Recent Development
11.17 Biobank
11.17.1 Biobank Company Detail
11.17.2 Biobank Business Overview
11.17.3 Biobank Biobanking Technologies Introduction
11.17.4 Biobank Revenue in Biobanking Technologies Business (2019-2024)
11.17.5 Biobank Recent Development
11.18 Biorep
11.18.1 Biorep Company Detail
11.18.2 Biorep Business Overview
11.18.3 Biorep Biobanking Technologies Introduction
11.18.4 Biorep Revenue in Biobanking Technologies Business (2019-2024)
11.18.5 Biorep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
